Browsing Tag
Africa
31 posts
Anupam Rasayan to acquire up to 48.2% stake in Bliss GVS Pharma as #ANURAS expands pharma value-chain bet
Anupam Rasayan is moving beyond chemistry into formulations. Can the Bliss GVS Pharma deal justify the market’s high expectations?
Changan Automobile partners with Portugal National Football Team to sharpen global mobility push
Changan needs global trust, not just new models. The Portugal football deal tests whether sports visibility can move car buyers.
Vodafone (LSE: VOD) sinks 9% as Germany customer losses overshadow FY26 cash flow beat
Vodafone beat guidance and raised the dividend. Shares fell 9% anyway. Germany lost 77k contract customers in Q4, and FY27 is guided lower. Why retail is split.
Gujarat Themis Biosyn (GUJTHEM) bets on global branded generics with €158m Sanofi portfolio deal
Find out how Gujarat Themis Biosyn’s €158m Sanofi portfolio deal could reshape its global anti-infective growth strategy.
How rare disease medicine access in Africa is moving from ad hoc supply to structured compliance-led programs
How Veld Pharmaceuticals and Chiesi are reshaping rare disease drug access in Africa through compliance-led programs. Read what this means for the sector.
No fear: Pope Leo XIV refuses to back down after Trump’s Truth Social attack
Pope Leo XIV says he has no fear of Trump and will keep speaking out against the Iran war, after the US president publicly attacked the Vatican's peace position.
Why Dai Nippon Printing chose Hyderabad for its second overseas R&D hub as 7912 retreats from 52-week highs
Dai Nippon Printing (TSE: 7912) opens an IIT Hyderabad R&D base for EV wireless charging and pharma APIs. Read the full strategic analysis.
Can India anchor U.S. Indo-Pacific goals? Trump’s 2025 strategy puts it at the center
India named a critical partner in Trump’s 2025 security strategy. Explore how it fits into U.S. Indo-Pacific, minerals, and South China Sea deterrence plans.
Lisk launches $15m venture fund to accelerate Web3 startups in emerging markets
Lisk launches $15m EMpower Fund to back Web3 startups in Africa, Latin America, and Southeast Asia. Find out why emerging markets lead Web3 adoption.
H2 Global Group enters growth phase with hydrogen therapy for Alzheimer’s and neurodegenerative diseases
H2 Global Group eyes EU and FDA milestones as it advances hydrogen therapy for Alzheimer’s and projects $48M revenues by 2029—read the in-depth analysis.